Cabio Biotech (Wuhan) Co., Ltd.

SHSE:688089 Stok Raporu

Piyasa değeri: CN¥3.4b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Cabio Biotech (Wuhan) Yönetim

Yönetim kriter kontrolleri 3/4

Cabio Biotech (Wuhan)'s CEO is Dewei Yi, appointed in Dec 2015, has a tenure of 8.83 years. directly owns 1.39% of the company’s shares, worth CN¥47.30M. The average tenure of the management team and the board of directors is 8.8 years and 5.8 years respectively.

Anahtar bilgiler

Dewei Yi

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi8.8yrs
CEO sahipliği1.4%
Yönetim ortalama görev süresi8.8yrs
Yönetim Kurulu ortalama görev süresi5.8yrs

Son yönetim güncellemeleri

Recent updates

Subdued Growth No Barrier To Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) With Shares Advancing 31%

Oct 01
Subdued Growth No Barrier To Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) With Shares Advancing 31%

There's Reason For Concern Over Cabio Biotech (Wuhan) Co., Ltd.'s (SHSE:688089) Massive 25% Price Jump

Aug 06
There's Reason For Concern Over Cabio Biotech (Wuhan) Co., Ltd.'s (SHSE:688089) Massive 25% Price Jump

Cabio Biotech (Wuhan) (SHSE:688089) Could Be Struggling To Allocate Capital

Jun 07
Cabio Biotech (Wuhan) (SHSE:688089) Could Be Struggling To Allocate Capital

Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

May 06
Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

Cabio Biotech (Wuhan)'s (SHSE:688089) Promising Earnings May Rest On Soft Foundations

May 03
Cabio Biotech (Wuhan)'s (SHSE:688089) Promising Earnings May Rest On Soft Foundations

The Market Lifts Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Shares 27% But It Can Do More

Mar 21
The Market Lifts Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Shares 27% But It Can Do More

CEO

Dewei Yi (59 yo)

8.8yrs

Görev süresi

CN¥1,179,900

Tazminat

Mr. Dewei Yi is Chairman of the Board & General Manager of CABIO Biotech(Wuhan) Co., Ltd., since December 2015. From December 1999 he has been the chairman of Wuhan Xiwang Biological Engineering Co., Ltd.;...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Dewei Yi
Chairman of the Board & GM8.8yrsCN¥1.18m1.39%
CN¥ 47.3m
Huabiao Wang
CFO & Director8.8yrsCN¥999.30k0.66%
CN¥ 22.5m
Huarong Yi
Board Secretary & Deputy GM2.8yrsCN¥620.30k0.089%
CN¥ 3.0m
Zhiming Wang
Deputy General Manager2.8yrsCN¥794.60k0.14%
CN¥ 4.8m
Min Xiao
Chief Engineer & Application Technology Director8.8yrsVeri yok0.042%
CN¥ 1.4m

8.8yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: 688089's management team is seasoned and experienced (8.8 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Dewei Yi
Chairman of the Board & GM8.8yrsCN¥1.18m1.39%
CN¥ 47.3m
Huabiao Wang
CFO & Director8.8yrsCN¥999.30k0.66%
CN¥ 22.5m
Bin Du
Vice Chairman of the Board8.8yrsCN¥990.70k0.58%
CN¥ 19.8m
Junyu Wu
Employee Supervisor8.8yrsVeri yok0.018%
CN¥ 620.5k
Chunyu Zhang
Director2.8yrsVeri yokVeri yok
Xiangdong Chen
Independent Director2.8yrsCN¥80.00kVeri yok
Qi Liu
Independent Director2.8yrsCN¥80.00kVeri yok
Jing Chen
Supervisor2.8yrsVeri yokVeri yok

5.8yrs

Ortalama Görev Süresi

53.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 688089's board of directors are considered experienced (5.8 years average tenure).